Chop chemotherapy in non-Hodgkin's lymphoma: Prognostic factors in 123 patients

被引：0
|
作者：
Pedro, C [1 ]
Besses, C [1 ]
Paez, A [1 ]
Acin, P [1 ]
Monzo, S [1 ]
Asensio, A [1 ]
SansSabrafen, J [1 ]
机构：
[1] HOSP ALIANCA,UNITAT HEMATOL & ONCOL 1973,BARCELONA,SPAIN
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1376 / 1376
页数：1
相关论文
共 50 条
  • [41] The lived experience of patients with non-Hodgkin's lymphoma undergoing chemotherapy
    Chircop, Daren
    Scerri, Josianne
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2018, 35 : 117 - 121
  • [42] Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy
    Lyman, GH
    Morrison, VA
    Dale, DC
    Crawford, J
    Delgado, DJ
    Fridman, M
    LEUKEMIA & LYMPHOMA, 2003, 44 (12) : 2069 - 2076
  • [43] Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma
    Mori, M
    Niitsu, N
    Takagi, T
    Tomiyama, J
    Matsue, T
    Nakagawa, Y
    Okamoto, R
    LEUKEMIA & LYMPHOMA, 2001, 41 (3-4) : 359 - 366
  • [44] Full-dose CHOP chomotherapy in elderly patients with non-Hodgkin's lymphoma
    Epeilbaum, R.
    Hain, N.
    Leblor, M.
    Ben-Shahar, M.
    Ben-Arie, Y.
    Dror, Y.
    Faraggi, D.
    Acta Oncologica, 34 (01):
  • [45] Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma
    Giles, FJ
    Vose, JM
    Do, KA
    Johnson, MM
    Manshouri, T
    Bociek, G
    Bierman, PJ
    O'Brien, SM
    Kantarjian, HM
    Armitage, JO
    Albitar, M
    LEUKEMIA RESEARCH, 2004, 28 (06) : 595 - 604
  • [46] Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
    Vose, JM
    Link, BK
    Grossbard, ML
    Czuczman, M
    Grillo-Lopez, A
    Gilman, P
    Lowe, A
    Kunkel, LA
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 389 - 397
  • [47] THE BORTEZOMIB plus CHOP SCHEME IN PATIENTS WITH REFRACTORY FORM OF NON-HODGKIN'S LYMPHOMA
    Karakulov, R. K.
    Gabbasova, S. T.
    Nassipov, B. A.
    Sagindykov, G. A.
    Jazyltayeva, A. S.
    Onalbaeva, J. C.
    LEUKEMIA RESEARCH, 2014, 38 : S26 - S26
  • [48] Prognostic factors and long follow-up in non-Hodgkin's lymphoma
    Llanos, M
    Cruz, J
    Oramas, J
    Aleman, R
    Dorta, J
    Morales, M
    Batista, N
    ANNALS OF ONCOLOGY, 1998, 9 : 110 - 111
  • [49] Prognostic factors and therapeutic efficacy of combined radio-chemotherapy in Waldeyer's ring non-Hodgkin lymphoma
    Yong, WB
    Zhang, YT
    Zheng, W
    Wei, Y
    CHINESE MEDICAL JOURNAL, 2000, 113 (02) : 148 - 150
  • [50] Prognostic factors in aggressive primary gastrointestinal non-Hodgkin's lymphoma.
    Ryu, MH
    Huh, J
    Heo, DS
    Ryoo, BY
    Song, HS
    Kim, HJ
    Eo, WK
    Chung, JS
    Bang, SM
    Kang, YK
    BLOOD, 2002, 100 (11) : 295B - 295B
12345